health pharma news today obesity drugs glp-1 today Alarming rise in weight loss drug overdoses GLP‑1 real‑world data for obesity:

PMID: 37222574

Several lines of evidence support a role for GIP in GLP-1 secretion

You can find additional information about the risks of FDA-approved medications that contain semaglutide here

Illustration of the mechanism of action in the GIPR/CRE Luciferase Reporter HEK293 Cell Line

Oral GLP-1 pills have not been studied alongside GLP-1 injectables so far, and researchers don't yet know which version may more more effective than the other

2 Neurological and behavioral models Because GLP-1R agonists cross the blood-brain barrier to influence appetite via hypothalamic signaling and reward pathways, researchers are increasingly interested in how these peptides affect preclinical models related to the central nervous system